Showing 1561-1570 of 8892 results for "".
The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.The Microbiome and Its Impact on Antibiotic Use in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-microbiome-and-its-impact-on-antibiotic-use-in-dermatology/23278/Despite focus on the clinical consequences of overusing antibiotics for decades, relatively little has been said about the potential impact on the microbiome.BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianAdvances in the Treatment of Reticular Erythematous Mucinosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/advances-in-the-treatment-of-reticular-erythematous-mucinosis/23491/Considering nicotinamide’s anti-inflammatory properties for inflammatory dermatological conditions to avoid steroid and antibiotic overuse.DataDerm Update
https://practicaldermatology.com/topics/practice-management/dataderm-update/23891/Joining can do a lot for your practice and patients.It is Time to Move Beyond Mushroom Tyrosinase. And Is Hydroquinone What We Think It Is?
https://practicaldermatology.com/topics/pigmentary-disorders/it-is-time-to-move-beyond-mushroom-tyrosinase-and-is-hydroquinone-what-we-think-it-is/23768/New research is offering better clinical clues about the action of tyrosinase inhibitors.Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicAcne and Rosacea: Quality of Life and Lifestyle Insights
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-quality-of-life-and-lifestyle-insights/23516/Acne and rosacea have causes and effects well beyond the skin.Preparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.